Navigation Links
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Date:8/21/2008

me to recurrence, patient-reported outcomes, plasma biomarkers, safety and tolerability.

The study is enrolling patients with all HCC histologies. Patients will be randomized to receive 400 mg of Nexavar twice daily or matching placebo for up to four years. The study will be conducted at more than 200 sites in North America, South America, Europe and the Asia-Pacific region, including Japan. For information about enrolling in the study, please visit http://www.clinicaltrials.gov.

Hepatocellular carcinoma is the most common form of liver cancer and is responsible for about 90 percent of the primary malignant liver tumors in adults. Liver cancer is the sixth most common cancer in the world and the third leading cause of cancer-related deaths globally. More than 600,000 cases of liver cancer are diagnosed worldwide each year (more than 400,000 in China, South Korea, Japan and Taiwan, 54,000 in the European Union, and 15,000 in the United States) and the incidence is increasing. In 2002, approximately 600,000 people died of liver cancer including approximately 370,000 in China, South Korea and Japan, 57,000 in the European Union, and 13,000 in the United States.(1,2)

Currently there are no adjuvant treatments with proven benefit in HCC and half of the patients who have undergone surgical resection or local ablation will see their tumors return within three years and 70 percent will see their tumors return within five years.(3)

Nexavar's Differentiated Mechanism

Nexavar targets both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has been shown to target members of two classes of kinases known to be involved in both cell proliferation (growth) and angiogenesis (blood supply) -- two important processes that enable cancer growth. These kinases included Raf kinase, VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-B, KIT, FLT-3 and RET.

Nexavar is currently approved in m
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCarePharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
2. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
6. Genzyme and Isis Begin Second Phase 3 Trial Of Mipomersen
7. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
8. Catalyst Pharmaceutical Partners, Inc. Begins Enrollment for U.S. Phase II Clinical Trial of CPP-109 in Patients with Methamphetamine Addiction
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014  AnaptysBio, Inc., a leader in the ... the appointment of Marco Londei , M.D. ... the preclinical and clinical development of AnaptysBio,s proprietary ... to welcome Dr. Londei to AnaptysBio,s executive leadership ... Chief Executive Officer of AnaptysBio. "Dr. Londei,s extensive ...
(Date:10/20/2014)... , Oct. 20, 2014   Mary,s Medicinals ... Caring, is a 4-Star Sponsor of Operation Grow4Vets ... with unique products, programs and services to assist them ... Key Facts: , An ever-increasing ... a safe and effective treatment for pain, Post-traumatic Stress ...
(Date:10/19/2014)... -- CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) ... 2014 financial results on Wednesday, October 29, 2014, after ... announcement, members of the management team will host a ... a general corporate update at 4:30 p.m. EDT (1:30 ... as follows: Wednesday, October 29 1:30 ...
Breaking Medicine Technology:AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2
... The National Community Pharmacists Association today endorsed H.R. 5234, the ... aim to reduce health care costs by requiring greater transparency of ... plan administrators, such as CVS Caremark, Express Scripts, Inc. and Medco ... , ...
... 6 An innovative catheter-based procedure is providing relief to patients ... of a severely leaky heart valve, but who are too sick for ... Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions. , ... Data from the Endovascular Valve Edge-to-Edge ...
Cached Medicine Technology:NCPA Applauds Rep. Weiner for Introducing Bill to Rein in Pharmacy Benefit Manager Practices That Hurt Patients, Plan Sponsors and Community Pharmacies 2NCPA Applauds Rep. Weiner for Introducing Bill to Rein in Pharmacy Benefit Manager Practices That Hurt Patients, Plan Sponsors and Community Pharmacies 3MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 3MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 4
(Date:10/19/2014)... 2014 Hastings and Hastings, a Phoenix ... service throughout the greater Phoenix area and across Arizona ... regard to catastrophic automobile accidents. Statistics have indicated a ... throughout Arizona. As such, Hastings and Hastings has seen ... for those who have been injured through no fault ...
(Date:10/19/2014)... October 19, 2014 Dr. Babatunde Osotimehin, ... welcomes news of a ceasefire agreement that is expected ... 200 girls who were kidnapped from the north-eastern Nigerian ... in captivity long enough, and it is high time ... stated Dr. Osotimehin. , "We owe it to these ...
(Date:10/19/2014)... Recently, Top10BestSEOHosting.com has unveiled its newest hosting ... HostMonster are the best VPS hosting suppliers in ... the method of partitioning a physical server computer ... appearance and capabilities of running on someone’s own ... close attention to VPS products and related suppliers. ...
(Date:10/19/2014)... NC (PRWEB) October 19, 2014 ... building program has just been released to the ... the online body building and fitness community. The ... attention of DietsAndFitnessGuides.com's Vin Delmonico prompting an investigative ... experience of hitting what is commonly known as ...
(Date:10/19/2014)... is a systemic disease that causes inflammation in ... affected members of the ancient Egyptian royal families. ... & Rheumatology , a journal of the American ... instead a degenerative spinal condition called diffuse idiopathic ... the 18th to early 20th Dynasties. , ...
Breaking Medicine News(10 mins):Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:The Best VPS Hosting Suppliers In The Market Unveiled By Top10BestSEOHosting.com 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2Health News:Mummy remains refute antiquity of ankylosing spondylitis 2
... , , , DENVER, July 16 ... been named the best respiratory hospital in the nation by U.S. ... "We are gratified that board-certified pulmonologists around the country continue to ... respiratory care," said Michael Salem, MD, President and CEO of National Jewish ...
... , PALO ALTO, Calif., July 16 ... chairman of the company,s Board of Directors. , ... and as the former chairman of Connetics Corporation and Oclassen Pharmaceuticals, ... to TOPICA, as well as an exceptional knowledge of the dermatology ...
... DANVERS, Mass., July 16 The Scleroderma ... is holding the Gateway to Hope 2009 National Patient Education Conference ... disease without a known cure, affects an estimated 300,000 people in ... causes collagen to build up in the tissues of the skin ...
... their sights on the bone malignancy chordoma , THURSDAY, July 16 ... that doctors explained away as lazy eye or asthma. , ... fell three times in one hour. On the baseball field, he ... it would fall to the ground, 10 feet away. , ...
... , WASHINGTON, July 16 U.S. News Media ... today announced the 2009-10 publication of America,s Best Hospitals, accessible today ... newsstands Tuesday, July 21. , , ... guide is the most extensive hospital ranking to-date. It includes rankings ...
... XIANYANG, China, July 16 /PRNewswire-Asia-FirstCall/ ... or "the Company"),a Xianyang-based developer, manufacturer and supplier ... of diseases and conditions,today announced it has received ... Capsules, and Shengjing Capsules. The Company is ready ...
Cached Medicine News:Health News:National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year 2Health News:TOPICA Elects G. Kirk Raab as Chairman of the Board 2Health News:Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St. Louis, Mo. 2Health News:Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St. Louis, Mo. 3Health News:Teaming Up to Tackle a Deadly Cancer 2Health News:Teaming Up to Tackle a Deadly Cancer 3Health News:Teaming Up to Tackle a Deadly Cancer 4Health News:U.S. News Media Group Announces 2009-10 America's Best Hospitals 2Health News:U.S. News Media Group Announces 2009-10 America's Best Hospitals 3Health News:U.S. News Media Group Announces 2009-10 America's Best Hospitals 4Health News:Biostar Pharmaceuticals, Inc. Receives Government Approvals for Three New Products 2Health News:Biostar Pharmaceuticals, Inc. Receives Government Approvals for Three New Products 3Health News:Biostar Pharmaceuticals, Inc. Receives Government Approvals for Three New Products 4
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
Medicine Products: